Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer’s rogue exec strikes back

Executive Summary

Peter Rost files a wrongful termination suit against Pfizer, CEO Hank McKinnell and other senior executives Dec. 12. Rost's suit alleges the defendants violated the N.J. Conscientious Employee Protection Act, which prohibits companies from retaliating against whistleblowers. Pfizer terminated Rost, who held the title VP-marketing, Dec. 1 following the unsealing of a qui tam lawsuit in which Rost alleges Pharmacia promoted the human growth hormone product Genotropin off-label prior to Pifzer's acquisition of the company in 2003 (1"The Pink Sheet" Dec. 5, 2005, In Brief). The Boston U.S. Attorney chose not to intervene in the lawsuit. Rost has been an outspoken advocate of pharmaceutical importation...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel